Shares of Open Text Corp. (TSE:OTC – Get Free Report) have been given a consensus rating of “Moderate Buy” by the six research firms that are currently covering the company, Marketbeat.com reports. Four analysts have rated the stock with a hold recommendation and two have issued a strong buy recommendation on the company.
OTC has been the topic of a number of recent analyst reports. Scotiabank upgraded shares of Open Text from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, September 24th. National Bank Financial upgraded shares of Open Text from a “hold” rating to a “strong-buy” rating in a research note on Sunday, September 14th. TD Securities upgraded Open Text to a “hold” rating in a research report on Friday, October 3rd. Finally, Jefferies Financial Group downgraded Open Text from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 12th.
Read Our Latest Analysis on OTC
Open Text Stock Performance
Open Text Company Profile
Ocumetics Technology Corp is a research and product development company that specializes in adaptive lens designs. It is in the pre-clinical stage of a game-changing technology for the ophthalmic industry – the Bionic Lens. The Bionic Lens is an expandable intraocular lens that fits within the natural lens compartment of the eye to completely eliminate the need for corrective lenses.
Further Reading
- Five stocks we like better than Open Text
- 3 REITs to Buy and Hold for the Long Term
- 4 Cold-Weather Stocks to Buy as Winter Spending Heats Up
- Using the MarketBeat Stock Split Calculator
- Disney Stock Drops—Will Earnings Pave Way for a YouTube TV Truce?
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
Receive News & Ratings for Open Text Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Open Text and related companies with MarketBeat.com's FREE daily email newsletter.
